|
Post by peppy on May 8, 2024 15:16:54 GMT -5
Diluted EPS. GAAP 0.04 Non-GAAP adjusted. $15,099. $0.05 Weighted average shares used to compute net income (loss) per share – diluted 324,733 * 2023. 263,969
|
|
|
Post by letitride on May 8, 2024 15:17:58 GMT -5
Love It!
|
|
|
Post by peppy on May 8, 2024 15:19:40 GMT -5
|
|
|
Post by boytroy88 on May 8, 2024 15:19:40 GMT -5
Great find! FAST! Before the PR! Thx Just happened to be in my brokerage account when it dropped there first! Which brokerage are you with?
|
|
|
Post by akemp3000 on May 8, 2024 15:19:44 GMT -5
It hit the high of the analysts projections in both revenue ($66M) and earnings ($.04). Very nice!
|
|
|
Post by wyattdog on May 8, 2024 15:20:19 GMT -5
edgar.com/20240508/AA22N222ZZ22KT8S22JA2Z42M9PBJK22Z262/
|
|
|
Post by porkini on May 8, 2024 15:24:30 GMT -5
Just happened to be in my brokerage account when it dropped there first! Which brokerage are you with? Fidelity, happy with them since moving there a couple years ago!
|
|
|
Post by Clement on May 8, 2024 15:32:37 GMT -5
"Collaborations and services revenue increased $13.5 million, or 118%, compared to the same period in 2023 primarily attributable to an increase in manufacturing Tyvaso DPI for United Therapeutics ("UT")." investors.mannkindcorp.com/node/19711/html#mnkd-ex99_1.htmSo where is all that T-DPI going that's not going to sales that generate royalties? What is UTHR doing with it?
|
|
|
Post by boytroy88 on May 8, 2024 15:37:10 GMT -5
Which brokerage are you with? Fidelity, happy with them since moving there a couple years ago! I'm with them also but looked at my other two brokerage instead. Love their APR for bank sweep. Hope they continue to keep that percentage where it's at.
|
|
|
Post by celo on May 8, 2024 15:39:19 GMT -5
Fidelity, happy with them since moving there a couple years ago! I'm with them also but looked at my other two brokerage instead. Love their APR for bank sweep. Hope they continue to keep that percentage where it's at. You get about 5%?
|
|
|
Post by ktim on May 8, 2024 15:40:35 GMT -5
"Collaborations and services revenue increased $13.5 million, or 118%, compared to the same period in 2023 primarily attributable to an increase in manufacturing Tyvaso DPI for United Therapeutics ("UT")." investors.mannkindcorp.com/node/19711/html#mnkd-ex99_1.htmSo where is all that T-DPI going that's not going to sales that generate royalties? It may be that T-DPI product/device revenue gets recognized a little quicker than the associated royalty, so when the market is growing in a non-linear way that would complicate matching collaboration and services against royalties. Also, some of the collaboration and services has been based on efforts to increase the manufacturing capacity. So the amount of that occurring in a quarter would mess with the ratio of collaboration and services vs royalty. Likely too many moving parts in this to bother trying to parse out the factors.
|
|
|
Post by letitride on May 8, 2024 15:44:13 GMT -5
"Collaborations and services revenue increased $13.5 million, or 118%, compared to the same period in 2023 primarily attributable to an increase in manufacturing Tyvaso DPI for United Therapeutics ("UT")." investors.mannkindcorp.com/node/19711/html#mnkd-ex99_1.htmSo where is all that T-DPI going that's not going to sales that generate royalties? What is UTHR doing with it? Maybe its not all TDPI.
|
|
|
Post by peppy on May 8, 2024 15:47:15 GMT -5
|
|
|
Post by ktim on May 8, 2024 15:47:18 GMT -5
Fidelity, happy with them since moving there a couple years ago! I'm with them also but looked at my other two brokerage instead. Love their APR for bank sweep. Hope they continue to keep that percentage where it's at. Yeah, I really hate all the other brokerages that basically did away with money market sweeping when they switched to no fee trades. I can't count how many times with Schwab or TD, I've bought something, forget to sell some of the money market and ended up paying margin interest for a few days before noticing it. I'm betting they make a LOT of money off the difference in what they get for holding peoples' cash and what they pay. It's a pet peeve, thus me trying to make sure I never have money sitting in cash. I do like Fidelity for that, but not as much for other capabilities of trading.
|
|
|
Post by akemp3000 on May 8, 2024 15:47:20 GMT -5
It's getting really close to the time for the market to start paying attention
|
|